1. Home
  2. LINK vs GANX Comparison

LINK vs GANX Comparison

Compare LINK & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINK
  • GANX
  • Stock Information
  • Founded
  • LINK 1984
  • GANX 2017
  • Country
  • LINK United States
  • GANX United States
  • Employees
  • LINK N/A
  • GANX N/A
  • Industry
  • LINK Industrial Machinery/Components
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINK Technology
  • GANX Health Care
  • Exchange
  • LINK Nasdaq
  • GANX Nasdaq
  • Market Cap
  • LINK 46.9M
  • GANX 53.4M
  • IPO Year
  • LINK N/A
  • GANX 2021
  • Fundamental
  • Price
  • LINK $8.04
  • GANX $1.88
  • Analyst Decision
  • LINK
  • GANX Strong Buy
  • Analyst Count
  • LINK 0
  • GANX 5
  • Target Price
  • LINK N/A
  • GANX $8.00
  • AVG Volume (30 Days)
  • LINK 45.3K
  • GANX 370.0K
  • Earning Date
  • LINK 08-13-2025
  • GANX 08-12-2025
  • Dividend Yield
  • LINK N/A
  • GANX N/A
  • EPS Growth
  • LINK N/A
  • GANX N/A
  • EPS
  • LINK N/A
  • GANX N/A
  • Revenue
  • LINK $11,735,000.00
  • GANX N/A
  • Revenue This Year
  • LINK $8.30
  • GANX N/A
  • Revenue Next Year
  • LINK $15.32
  • GANX N/A
  • P/E Ratio
  • LINK N/A
  • GANX N/A
  • Revenue Growth
  • LINK N/A
  • GANX N/A
  • 52 Week Low
  • LINK $3.25
  • GANX $0.95
  • 52 Week High
  • LINK $10.90
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • LINK 55.71
  • GANX 58.97
  • Support Level
  • LINK $7.90
  • GANX $1.80
  • Resistance Level
  • LINK $9.55
  • GANX $1.96
  • Average True Range (ATR)
  • LINK 0.79
  • GANX 0.16
  • MACD
  • LINK 0.12
  • GANX 0.03
  • Stochastic Oscillator
  • LINK 61.18
  • GANX 64.18

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: